Seelos Therapeutics, Inc.: cash_and_equivalents

Value{"amount": 8463000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2017-09-30)
Statuscurrent
EntitySeelos Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001017491-17-000125 · Open the official SEC filing →
Retrieved: 2026-08-19T09:53:13.881238+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001017491/cash-and-equivalents/2017-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/ca4f32b0-36e8-4978-8aed-5f9c4d155d9d

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies